CTLA4 and cancer: Widely utilized cancer immunotherapy approaches include immune checkpoint blockade therapy directed against immune checkpoint proteins (e.g., PD-1, PD-L1, CTLA-4, TIM-3, VISTA), chimeric antigen receptor T (CAR-T) cells, dendritic cell vaccines, and cytokines, among others [15,16,17,18,19,20].